Search Results - tobias+hoffmann

1 Results Sort By:
Novel Targets and Compounds to Treat Bladder Cancer
Alternative splicing modulating antisense oligonucleotides (ASOs) targeting novel identified alternative splicing changes associated with RBM10 mutations in bladder cancer. We are developing lead ASOs to treat bladder, and eventually other, cancers. Technology: Bladder cancer is the 9th most common malignant disease worldwide and 13 most frequent...
Published: 8/6/2025   |   Inventor(s): Juan Valcarcel, Ángel Guerra, Tobias Hoffmann
Keywords(s):  
Category(s): Biotechnology, Drug Targets & Mechanisms, Therapeutics (Biologics & Compounds)